HEADER CELL CYCLE 16-OCT-00 1E9H TITLE THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE TITLE 2 INHIBITOR INDIRUBIN-5-SULPHONATE BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CYCLIN-DEPENDENT KINASE 2, CDK2; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: PHOSPHORYLATED ON THR 160 CHAINS A AND C ARE ASYMETRIC COMPND 8 UNIT COPIES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLIN A3; COMPND 11 CHAIN: B, D; COMPND 12 SYNONYM: A3; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: TRUNCATED FRAGMENT OF CYCLIN A. IN COMPLEX WITH CDK2 COMPND 15 CHAINS B AND D ARE ASYMETRIC UNIT COPIES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CELL CYCLE, COMPLEX (PROTEIN KINASE-CYCLIN), KINASES, INHIBITOR, KEYWDS 2 CYCLIN, COMPLEX, PHOSPHORYLATION EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES,P.TUNNAH,M.E.M.NOBLE,J.A.ENDICOTT REVDAT 5 01-MAY-24 1E9H 1 LINK REVDAT 4 24-FEB-09 1E9H 1 VERSN REVDAT 3 07-JUN-06 1E9H 1 REMARK CRYST1 REVDAT 2 26-NOV-01 1E9H 1 JRNL REVDAT 1 11-OCT-01 1E9H 0 JRNL AUTH T.G.DAVIES,P.TUNNAH,L.MEIJER,D.MARKO,G.EISENBRAND, JRNL AUTH 2 J.A.ENDICOTT,M.E.NOBLE JRNL TITL INHIBITOR BINDING TO ACTIVE AND INACTIVE CDK2: THE CRYSTAL JRNL TITL 2 STRUCTURE OF CDK2-CYCLIN A/INDIRUBIN-5-SULPHONATE JRNL REF STRUCTURE V. 9 389 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11377199 JRNL DOI 10.1016/S0969-2126(01)00598-6 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 52335 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8938 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 369 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.459 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1E9H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1290005449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47127 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: UNPUBLISHED STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.90050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.21800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.90200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.21800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.90050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.90200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE CDK2 SHOWS MAXIMAL ACTIVITY DURING S PHASE AND G2 AND REMARK 400 INTERACTS WITH CYCLINS A, D, OR E. IT IS PROBABLY REMARK 400 INVOLVED IN THE CONTROL OF THE CELL CYCLE. REMARK 400 CYCLIN IS ESSENTIAL FOR THE CONTROL OF THE CELL CYCLE AT THE REMARK 400 G1/S(START) AND THE G2/M (MITOSIS) TRANSITIONS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 LEU B 433 REMARK 465 ASN B 434 REMARK 465 LEU B 435 REMARK 465 LEU D 433 REMARK 465 ASN D 434 REMARK 465 LEU D 435 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TRP A 227 O HOH A 2094 1.73 REMARK 500 N VAL A 230 O HOH A 2094 1.89 REMARK 500 O HOH A 2034 O HOH A 2090 1.96 REMARK 500 O HOH A 2106 O HOH A 2109 2.13 REMARK 500 N GLY A 229 O HOH A 2094 2.15 REMARK 500 O HOH B 2014 O HOH B 2097 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO C 234 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO C 241 C - N - CA ANGL. DEV. = 23.7 DEGREES REMARK 500 PRO C 241 C - N - CD ANGL. DEV. = -20.9 DEGREES REMARK 500 PRO C 241 N - CA - C ANGL. DEV. = 17.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 8 143.42 -176.84 REMARK 500 ILE A 10 -37.43 -131.93 REMARK 500 LEU A 37 -96.69 -109.95 REMARK 500 ASP A 38 20.54 88.42 REMARK 500 THR A 39 -165.99 51.39 REMARK 500 GLU A 40 63.45 13.52 REMARK 500 THR A 41 -115.92 -156.91 REMARK 500 ALA A 95 -32.60 -34.15 REMARK 500 ASP A 127 38.64 -160.66 REMARK 500 ASP A 145 79.15 51.68 REMARK 500 PHE A 146 38.05 -95.02 REMARK 500 GLU A 162 69.60 -67.77 REMARK 500 VAL A 164 131.04 74.60 REMARK 500 SER A 181 -145.16 -138.97 REMARK 500 ARG A 199 7.43 86.57 REMARK 500 ALA A 201 125.37 -17.94 REMARK 500 PRO A 204 57.22 -91.09 REMARK 500 THR A 231 -10.22 -47.62 REMARK 500 ASP A 270 108.59 -58.72 REMARK 500 ILE A 275 140.66 -39.87 REMARK 500 LYS A 291 73.95 -106.40 REMARK 500 PRO A 292 -111.17 -52.81 REMARK 500 VAL A 293 156.54 178.64 REMARK 500 ASP B 283 49.79 38.17 REMARK 500 CYS B 327 -50.99 -29.98 REMARK 500 TRP B 372 114.63 -25.97 REMARK 500 TYR B 413 24.84 -77.90 REMARK 500 GLU C 8 128.65 -173.50 REMARK 500 TYR C 15 -85.54 -132.02 REMARK 500 ASP C 38 -6.61 63.01 REMARK 500 THR C 39 -134.08 82.05 REMARK 500 GLU C 40 111.18 -29.60 REMARK 500 THR C 41 -83.59 159.60 REMARK 500 GLU C 42 11.37 -142.55 REMARK 500 LEU C 96 -71.80 -87.91 REMARK 500 ASP C 127 38.08 -155.99 REMARK 500 LYS C 129 146.32 -176.84 REMARK 500 PRO C 130 -31.79 -38.23 REMARK 500 ASP C 145 80.97 46.31 REMARK 500 GLU C 162 79.61 -65.73 REMARK 500 VAL C 164 130.47 71.87 REMARK 500 LEU C 166 -69.86 -26.81 REMARK 500 SER C 181 -149.29 -163.61 REMARK 500 THR C 182 -37.81 -39.71 REMARK 500 ARG C 199 -7.34 93.42 REMARK 500 ASP C 223 161.11 160.73 REMARK 500 GLU C 224 -34.48 -32.67 REMARK 500 PRO C 234 -57.58 -11.86 REMARK 500 SER C 239 9.82 -60.41 REMARK 500 PRO C 241 162.19 23.35 REMARK 500 REMARK 500 THIS ENTRY HAS 68 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2001 DISTANCE = 5.91 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INR A1298 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INR C1298 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AQ1 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 STAUROSPORINE REMARK 900 RELATED ID: 1B38 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1B39 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 REMARK 900 RELATED ID: 1CKP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 PURVALANOL B REMARK 900 RELATED ID: 1DM2 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 HYMENIALDISINE REMARK 900 RELATED ID: 1E1V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 REMARK 900 RELATED ID: 1E1X RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 REMARK 900 RELATED ID: 1HCK RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1HCL RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1JSU RELATED DB: PDB REMARK 900 P27(KIP1)/CYCLIN A/CDK2 COMPLEX REMARK 900 RELATED ID: 1FIN RELATED DB: PDB REMARK 900 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX REMARK 900 RELATED ID: 1JST RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A REMARK 900 RELATED ID: 1QMZ RELATED DB: PDB REMARK 900 PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX DBREF 1E9H A 0 0 PDB 1E9H 1E9H 0 0 DBREF 1E9H A 1 296 UNP P24941 CDK2_HUMAN 1 296 DBREF 1E9H B 175 432 UNP P20248 CGA2_HUMAN 175 432 DBREF 1E9H C 0 0 PDB 1E9H 1E9H 0 0 DBREF 1E9H C 1 296 UNP P24941 CDK2_HUMAN 1 296 DBREF 1E9H D 175 432 UNP P20248 CGA2_HUMAN 175 432 SEQADV 1E9H TPO A 160 UNP P20248 THR 160 MODIFIED RESIDUE SEQRES 1 A 297 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 A 297 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 A 297 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 A 297 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 A 297 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 A 297 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 A 297 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 A 297 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 A 297 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 A 297 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 297 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 A 297 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 A 297 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 297 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 A 297 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 A 297 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 A 297 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 A 297 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 A 297 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 A 297 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 A 297 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 A 297 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 A 297 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU SEQRES 1 B 261 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 B 261 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 B 261 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 B 261 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 B 261 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 B 261 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 B 261 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 B 261 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 B 261 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 B 261 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 B 261 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 B 261 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 B 261 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 B 261 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 B 261 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 B 261 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 B 261 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 B 261 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 B 261 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 B 261 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU LEU ASN SEQRES 21 B 261 LEU SEQRES 1 C 297 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 C 297 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 C 297 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 C 297 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 C 297 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 C 297 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 C 297 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 C 297 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 C 297 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 C 297 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 C 297 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 C 297 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 C 297 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 C 297 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 C 297 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 C 297 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 C 297 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 C 297 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 C 297 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 C 297 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 C 297 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 C 297 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 C 297 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU SEQRES 1 D 261 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 D 261 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 D 261 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 D 261 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 D 261 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 D 261 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 D 261 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 D 261 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 D 261 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 D 261 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 D 261 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 D 261 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 D 261 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 D 261 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 D 261 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 D 261 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 D 261 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 D 261 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 D 261 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 D 261 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU LEU ASN SEQRES 21 D 261 LEU MODRES 1E9H TPO A 160 THR PHOSPHOTHREONINE MODRES 1E9H TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 11 HET INR A1298 24 HET INR C1298 24 HETNAM TPO PHOSPHOTHREONINE HETNAM INR 2',3-DIOXO-1,1',2',3-TETRAHYDRO-2,3'-BIINDOLE-5'- HETNAM 2 INR SULFONIC ACID HETSYN TPO PHOSPHONOTHREONINE HETSYN INR INDIRUBIN-5-SULPHONATE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 INR 2(C16 H10 N2 O5 S) FORMUL 7 HOH *369(H2 O) HELIX 1 1 PRO A 45 GLU A 57 1 13 HELIX 2 2 LEU A 87 ALA A 93 1 7 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 THR A 165 ARG A 169 5 5 HELIX 6 6 ALA A 170 LEU A 175 1 6 HELIX 7 7 THR A 182 ARG A 199 1 18 HELIX 8 8 SER A 207 GLY A 220 1 14 HELIX 9 9 GLY A 229 MET A 233 5 5 HELIX 10 10 ASP A 247 VAL A 251 5 5 HELIX 11 11 ASP A 256 LEU A 267 1 12 HELIX 12 12 SER A 276 LEU A 281 1 6 HELIX 13 13 ALA A 282 GLN A 287 5 6 HELIX 14 14 TYR B 178 LYS B 194 1 17 HELIX 15 15 TYR B 199 GLN B 203 5 5 HELIX 16 16 THR B 207 TYR B 225 1 19 HELIX 17 17 GLN B 228 LEU B 243 1 16 HELIX 18 18 LYS B 252 GLU B 269 1 18 HELIX 19 19 GLU B 274 ILE B 281 1 8 HELIX 20 20 THR B 287 LEU B 302 1 16 HELIX 21 21 THR B 310 PHE B 319 1 10 HELIX 22 22 LEU B 320 GLN B 322 5 3 HELIX 23 23 ASN B 326 ASP B 343 1 18 HELIX 24 24 ASP B 343 LEU B 348 1 6 HELIX 25 25 LEU B 351 GLY B 369 1 19 HELIX 26 26 PRO B 373 GLY B 381 1 9 HELIX 27 27 THR B 383 ALA B 401 1 19 HELIX 28 28 PRO B 402 HIS B 404 5 3 HELIX 29 29 GLN B 407 TYR B 413 1 7 HELIX 30 30 LYS B 414 HIS B 419 5 6 HELIX 31 31 GLY B 420 LEU B 424 5 5 HELIX 32 32 SER C 0 GLU C 2 5 3 HELIX 33 33 PRO C 45 LYS C 56 1 12 HELIX 34 34 LEU C 87 ALA C 93 1 7 HELIX 35 35 PRO C 100 HIS C 121 1 22 HELIX 36 36 LYS C 129 GLN C 131 5 3 HELIX 37 37 THR C 165 ARG C 169 5 5 HELIX 38 38 ALA C 170 LEU C 175 1 6 HELIX 39 39 THR C 182 ARG C 199 1 18 HELIX 40 40 SER C 207 GLY C 220 1 14 HELIX 41 41 GLY C 229 MET C 233 5 5 HELIX 42 42 ASP C 247 VAL C 252 1 6 HELIX 43 43 ASP C 256 LEU C 267 1 12 HELIX 44 44 SER C 276 LEU C 281 1 6 HELIX 45 45 HIS C 283 GLN C 287 5 5 HELIX 46 46 TYR D 178 VAL D 191 1 14 HELIX 47 47 THR D 207 TYR D 225 1 19 HELIX 48 48 GLN D 228 SER D 244 1 17 HELIX 49 49 LEU D 249 GLU D 269 1 21 HELIX 50 50 GLU D 274 ILE D 281 1 8 HELIX 51 51 THR D 287 LEU D 302 1 16 HELIX 52 52 THR D 310 LEU D 320 1 11 HELIX 53 53 ASN D 326 SER D 340 1 15 HELIX 54 54 PRO D 346 TYR D 350 5 5 HELIX 55 55 LEU D 351 THR D 368 1 18 HELIX 56 56 PRO D 373 GLY D 381 1 9 HELIX 57 57 LEU D 387 ALA D 401 1 15 HELIX 58 58 PRO D 402 HIS D 404 5 3 HELIX 59 59 ILE D 409 LYS D 414 1 6 HELIX 60 60 ASN D 415 HIS D 419 5 5 SHEET 1 A 5 PHE A 4 GLY A 11 0 SHEET 2 A 5 VAL A 18 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 A 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 A 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 A 5 LEU A 66 HIS A 71 -1 N LEU A 67 O VAL A 79 SHEET 1 B 3 GLN A 85 ASP A 86 0 SHEET 2 B 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 B 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 C 2 VAL A 123 LEU A 124 0 SHEET 2 C 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 D 5 PHE C 4 LYS C 9 0 SHEET 2 D 5 VAL C 18 ASN C 23 -1 O LYS C 20 N VAL C 7 SHEET 3 D 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 D 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 D 5 LEU C 66 HIS C 71 -1 N LEU C 67 O VAL C 79 SHEET 1 E 3 GLN C 85 ASP C 86 0 SHEET 2 E 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 E 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 F 2 VAL C 123 LEU C 124 0 SHEET 2 F 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.32 LINK C TPO A 160 N HIS A 161 1555 1555 1.33 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.33 CISPEP 1 VAL A 154 PRO A 155 0 -0.10 CISPEP 2 GLN B 323 PRO B 324 0 -0.35 CISPEP 3 ASP B 345 PRO B 346 0 0.60 CISPEP 4 VAL C 154 PRO C 155 0 -0.05 CISPEP 5 GLN D 323 PRO D 324 0 -0.48 CISPEP 6 ASP D 345 PRO D 346 0 0.34 SITE 1 AC1 14 ILE A 10 VAL A 18 ALA A 31 LYS A 33 SITE 2 AC1 14 PHE A 80 GLU A 81 PHE A 82 LEU A 83 SITE 3 AC1 14 HIS A 84 GLN A 85 LYS A 89 LEU A 134 SITE 4 AC1 14 ALA A 144 ASP A 145 SITE 1 AC2 11 ALA C 31 LYS C 33 PHE C 80 GLU C 81 SITE 2 AC2 11 PHE C 82 LEU C 83 HIS C 84 GLN C 85 SITE 3 AC2 11 ASP C 86 LEU C 134 ASP C 145 CRYST1 73.801 133.804 150.436 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013550 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007474 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006647 0.00000 MTRIX1 1 -0.999932 -0.011239 0.003138 174.44279 1 MTRIX2 1 0.010826 -0.793178 0.608894 -1.51400 1 MTRIX3 1 -0.004354 0.608886 0.793246 0.70450 1